Genetic counseling for isolated GnRH deficiency

Molecular and Cellular Endocrinology

Volumn 346, Issue 1-2, 2011, Pages 102-109

  Au, Margaret G ^a   Crowley Jr , William F ^a   Buck, Cassandra L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Genetic counseling; GnRH deficiency; Kallmann syndrome

Indexed keywords

GONADORELIN;

ANXIETY; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC VARIABILITY; GONADORELIN DEFICIENCY; GUILT; HORMONE DEFICIENCY; HUMAN; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; NONHUMAN; PEDIGREE; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; RISK ASSESSMENT; SHAME; SOCIAL PSYCHOLOGY; X CHROMOSOME LINKED DISORDER;

ANIMALS; GENETIC COUNSELING; GENETIC TESTING; GONADOTROPIN-RELEASING HORMONE; HUMANS; PEDIGREE; PHENOTYPE; RISK ASSESSMENT;

EID: 80053386384     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.05.041     Document Type: Review

References (36)

1. Abreu A.P., Trarbach E.B., de Castro M., Frade Costa E.M., Versiani B., Matias Baptista M.T., Garmes H.M., Mendonca B.B., Latronico A.C. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. J. Clin. Endocrinol. Metab. 2008, 93:4113-4118.
2. American Society of Human Genetics Board of Directors and the American College of Medical Genetics Board of Directors, 1995. Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am. J. Hum. Genet. 57, 1233-41.
3. Baum A., Friedman A.L., Zakowski S.G. Stress and Genetic Testing for Disease Risk. Health Psychol. 1997, 16(1):8-19.
4. Bédécarrats G.Y., Kaiser U.B. Mutations in the human gonadotropin-releasing hormone receptor: insights into receptor biology and function. Semin. Reprod. Med. 2007, 25:368-378.
5. Bouligand J., Ghervan C., Tello J.A., Brailly-Tabard S., Salenave S., Chanson P., Lombes M., Millar R.P., Guiochon-Mantel A., Young J. Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. N. Engl. J. Med. 2009, 360:2742-2748.
6. Canto P., Munguia P., Soderlund D., Castro J.J., Mendez J.P. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1. J. Androl. 2009, 30:41-45.
7. Cerrato F., Shagoury J., Kralickova M., Dwyer A., Falardeau J., Ozata M., Van Vliet G., Bouloux P., Hall J.E., Hayes F.J., Pitteloud N., Martin K.A., Welt C., Seminara S.B. Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism. Eur. J. Endocrinol. 2006, 155(Suppl. 1):S3-S10.
8. Chan Y.M., de Guillebon A., Lang-Muritano M., Plummer L., Cerrato F., Tsiaras S., Gaspert A., Lavoie H.B., Wu C.H., Crowley W.F., Amory J.K., Pitteloud N., Seminara S.B. GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc. Natl. Acad. Sci. USA 2009, 106(28):11703-11708.
9. Cole L.W., Sidis Y., Zhang C., Quinton R., Plummer L., Pignatelli D., Hughes V.A., Dwyer A.A., Ravio T., Hayes F.J., Seminara S.B., Huot C., Alos N., Speiser P., Takeshita A., Van Vliet G., Pearce S., Crowley W.F., Zhou Q.Y., Pitteloud N. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. J. Clin. Endocrinol. Metab. 2008, 93:3551-3559.
10. de Roux N., Young J., Misrahi M., Genet R., Chanson P., Schaison G., Milgrom E. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N. Engl. J. Med. 1997, 337:1597-1602.
11. de Roux N., Genin E., Carel J-C., Fumihiko Matsuda F., Chaussain J-L., Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. PNAS 2003, 100(19):10972-10976.
12. Dode C., Teixeira L., Levilliers J., Fouveaut C., Bouchard P., Kottler M., Lespinasse J., Lienhardt-Roussie A., Mathieu M., Moerman A., Morgan G., Murat A., Toublanc J., Wolczynski S., Delpech M., Petit C., Young J., Hardelin J. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet. 2006, 2(10):e175.
13. Dode, C., Levilliers, J., Dupont, J.M., De Paepe, A., Le Du, N., Soussi-Yanicostas, N., Coimbra, R.S., Delmaghani, S., Compain-Nouaille, S., Baverel, F., Pecheux, C., Le Tessier, D., Cruaud, C., Delpech, M., Speleman, F., Vermeulen, S., Amalfitano, A., Bachelot, Y., Bouchard, P., Cabrol, S., Carel, J.C., Delemarre-van de Waal, H., Goulet-Salmon, B., Kottler, M.L., Richard, O., Sanchez-Franco, F., Saura, R., Young, J., Petit, C., Hardelin, J.P., 2003. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat. Genet. 33, 463-465.
14. Falardeau J., Chung W.C., Beenken A., Raivio T., Plummer L., Sidis Y., Jacobson-Dickman E.E., Eliseenkova A.V., Ma J., Dwyer A., Quinton R., Na S., Hall J.E., Huot C., Alois N., Pearce S.H., Cole L.W., Hughes V., Mohammadi M., Tsai P., Pitteloud N. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J. Clin. Invest. 2008, 118:2822-2831.
15. Georgopoulos N.A., Pralong F.P., Seidman C.E., Crowley W.F., Vallejo M. Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadtropin-releasing hormone deficiency. J. Clin. Endocrinol. Metab. 1997, 82(1):213-217.
16. Gianetti E., Tusset C., Noel S.C., Au M.G., Dwyer A.A., Hughes V.A., Abreu A.P., Carroll J., Trarbach E., Silveira L.F., Costa E.M., de Mendonca B.B., de Castro M., Lofrano A., Hall J.E., Bolu E., Ozata M., Quinto R., Amory J.K., Stewart S.E., Arlt W., Cole T.R., Crowley W.F., Kaiser U.B., Latronico A.C., Seminara S.B. TAC3/TACR3 mutations reveal preferential activiation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J. Clin. Endocrinol. Metab. 2010, 95:2857-2867.
17. Guran T., Tolhurst G., Bereket A., Rocha N., Porter K., Turan S., Gribble F.M., Kotan L.D., Akcay T., Atay Z., Canan H., Serin A., O'Rahilly S., Reimann F., Semple R.K., Topaloglu A.K. Hypogonadotropic hypogonadism due to a novel missense mutation in the first extracellular loop of the neurokinin B receptor. J. Clin. Endocrinol. Metab. 2009, 94:3633-3639.
18. Jongmans M.C., van Ravenswaaij-Arts C.M., Pitteloud N., Ogata T., Sato N., Claahsen-van der Grinten H.L., van der Donk K., Seminara S., Bergman J.E., Brunner H.G., Crowley W.F., Hoefsloot L.H. CHD7 mutations in patients initially diagnosed with Kallmann syndrome-the clinical overlap with CHARGE syndrome. Clin. Genet. 2009, 75:65-71.
19. Kim H.G., Kurth I., Lan F., Meliciani I., Wenzel W., Eom S.H., Kang G.B., Rosenberger G., Tekin M., Ozata M., Bick D.P., Sherins R.J., Walker S.L., Shi Y., Gusella J.F., Layman L.C. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am. J. Hum. Genet. 2008, 83:511-519.
20. Oliveira L.M., Seminara S.B., Beranova M., Hayes F.J., Valkenburgh S.B., Schipani E., Costa E.M., Latronico A.C., Crowley W.F., Vallejo M. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J. Clin. Endocrinol. Metab. 2001, 86:1532-1538.
21. Pallais J.C., Au M., Pitteloud N., Seminara S., Crowley W.F. Isolated gonadotropin-releasing hormone (GnRH) deficiency overview. Gene Rev. [Internet] 2010, Seattle, WA. R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens (Eds.).
22. Pitteloud N., Meysing A., Quinton R., Acierno J.S., Dwyer A.A., Plummer L., Fliers E., Boepple P., Hayes F., Seminara S., Hughes V.A., Ma J., Bouloux P., Mohammadi M., Crowley W.F. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Mol. Cell Endocrinol. 2006, 254-255:60-69.
23. Pitteloud N., Quinton R., Pearce S., Raivio T., Acierno J., Dwyer A., Plummer L., Hughes V., Seminara S., Cheng Y., Li W., Maccoll G., Eliseenkova A.V., Olsen S.K., Ibrahimi O.A., Hayes F.J., Boepple P., Hall J.E., Bouloux P., Mohammadi M., Crowley W. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J. Clin. Invest. 2007, 117:457-463.
24. Pitteloud N., Zhang C., Pignatelli D., Li J.D., Raivio T., Cole L.W., Plummer L., Jacobson-Dickman E.E., Mellon P.L., Zhou Q.Y., Crowley W.F. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc. Natl. Acad. Sci. USA 2007, 104:17447-17452.
25. Pedersen-White J.R., Chorich L.P., Bick D.P., Sherins R.J., Layman L.C. The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Mol. Hum. Repro. 2008, 14(6):367-370.
26. Pletcher B.A., Toriello H.V., Noblin S.J., Seaver L.H., Driscoll D.A., Bennett R.L., Gross S.J. Indications for genetic referral: a guide for healthcare providers. Genet. Med. 2007, 9(6):385-388.
27. Resta R., Biesecker B.B., Bennett R.L., Blum S., Hahn S.E., Strecker M.N., Williams J.L. A new definition of genetic counseling: national society of genetic counselors' task force report. J. Genet. Couns. 2006, 15(2):77-83.
28. Seminara S.B., Messager S., Chatzidaki E.E., Thresher R.R., Acierno J.S., Shagoury J.K., Bo-Abbas Y., Kuohung W., Schwinof K.M., Hendrick A.G., Zahn D., Dixon J., Kaiser U.B., Slaugenhaupt S.A., Gusella J.F., O'Rahilly S., Carlton M.B., Crowley W.F., Aparicio S.A., Colledge W.H. The GPR54 gene as a regulator of puberty. N. Engl. J. Med. 2003, 349:1614-1627.
29. Semple R.K., Achermann J.C., Ellery J., Farooqi I.S., Karet F.E., Stanhope R.G. Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 2005, 90:1849-1855.
30. Shaw, N.D., Seminara, S.B., Welt, C.K., Au, M.G., Plummer, L., Hughes, V.A., Dwyer, A.A., Martin, K.A., Quinton, R., Meriq, V., Merino, P.M., Gusella, J.F., Crowley W.F. Jr., Pitteloud N., Hall, J.E., 2011. Expanding the phenotype and genotype of female GnRH deficiency. J. Clin. Endocrinol. Metab. [Epub ahead of print].
31. Sykiotis G.P., Plummer L., Hughes V.A., Au M., Durrani S., Nayak-Young S., Dwyer A.A., Quinton R., Hall J.E., Gusella J.F., Seminara S.B., Crowley W.F., Pitteloud N. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc. Natl. Acad. Sci. USA 2010, 107:15140-15144.
32. Topaloglu A.K., Reimann F., Guclu M., Yalin A.S., Kotan L.D., Porter K.M., Serin A., Mungan N.O., Cook J., Ozbek M.N., Imamoglu S., Akalin N.S., Yuksel B., O'Rahilly S., Semple R.K. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat. Genet. 2009, 41:354-358.
33. Trarbach E.B., Abreu A.P., Silveira L.F., Garmes H.M., Baptista M.T., Teles M.G., Costa E.M., Mohammadi M., Pitteloud N., de Mendonca B.B., Latronico A.C. Nonsense mutations in FGF8 gene causing different degrees of human gonadotropin-releasing deficiency. J. Clin. Endocrinol. Metab. 2010, 95:3491-3496.
34. Trarbach E.B., Teles M.G., Frade Costa E.M., Abreu A.P., Garmes H.M., Guerre-Junior G., Matias Baptista M.T., de Castro M., Mendonca B.B., Latronico A.C. Screening of autosomal gene deletions in patients with hypogonadotropic hypogonadism using multiplex ligation-dependent probe amplification: detection of a hemizygosis for the fibroblast growth factor receptor 1. Clin. Endocrinol. 2010, 72:371-376.
35. Trarbach E.B., Costa E.M., Versiani B., de Castro M., Baptista M.T., Garmes H.M., de Mendonca B.B., Latronico A.C. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia. J. Clin. Endocrinol. Metab. 2006, 91:4006-4012.
36. Weil J. Psychosocial Genetic Counseling 2000, Oxford, New York, pp. 122-123.